对动脉样硬化和帕金森病的潜在常见致病机制的生物信息学分析
1Department of Neurology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Frontiers in aging neuroscience
|August 31, 2023
概括
这项研究确定了动脉样硬化和帕金森病之间的共同分子通路. 六个枢纽基因和特定的免疫细胞,如B细胞和巨细胞,都与这些神经系统疾病的共同病原发生有关.
科学领域:
- 神经科学是一个神经科学.
- 基因组学就是基因组学.
- 免疫学 免疫学 免疫学
背景情况:
- 动脉样硬化和帕金森病是常见的神经系统疾病,具有共同的危险因素.
- 研究它们的同时出现可以揭示潜在的生物机制.
研究的目的:
- 探索动脉样硬化和帕金森病之间的共同遗传和分子关联.
- 使用遗传数据库识别常见的差异表达基因 (DEG) 和枢纽基因.
主要方法:
- 从GEO数据库下载了动脉样硬化和帕金森病的基因表达特征.
- 识别了常见的DEG,构建了蛋白质-蛋白质相互作用网络,并使用LASSO回归识别了枢纽基因.
- 通过ROC分析评估了枢纽基因的诊断效率,并使用ssGSEA分析了免疫细胞透.
主要成果:
- 在动脉样硬化和帕金森病之间确定了50个共享的DEGs (36个上调,14个下调).
- 六个枢纽基因 (C1QB,CD53,LY96,P2RX7,C3,TNFSF13B或CD14) 被发现具有高诊断效率.
- 发现活性B细胞,效应记忆CD8+T细胞和巨细胞是常见的相关免疫细胞.
结论:
- 这项研究揭示了共享的分子机制和动脉样硬化和帕金森病的潜在生物标志物.
- 已识别的枢纽基因和免疫细胞概况为人们提供了对常见病变发生的洞察力.
- 这些发现需要对治疗策略进行进一步的实验验证.
相关概念视频
Parkinson's Disease: Overview
593
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
593
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
Genome-wide Association Studies-GWAS
13.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.6K
Coronary Artery Disease I: Introduction
20
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
20
Peripheral Artery Disease I: Introduction
9
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs but also impacts other areas, such as the arms, thereby impairing overall circulation and organ function.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty deposits inside the arterial...
9
Coronary Artery Disease II: Pathophysiology
12
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12


